Intrinsic Value of S&P & Nasdaq Contact Us

Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Conformis, Inc. (CFMS) reported total assets of $67.78M and total liabilities of $35.76M for quarter ending 2023-06-30, resulting in total equity of $32.03M.

The company held $26.18M in cash and short-term investments. Total debt stood at $26.58M, with net debt of $402K. The Debt-to-Equity (D/E) ratio was 0.83 (moderate).

Current ratio is 5.07, indicating strong short-term liquidity. Interest coverage is -18.4x (weak).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (21/100) — Total assets $67.78M and equity $32.03M support the company's competitive scale

Overall SharesGrow Score: 19/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
19/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
21/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Conformis, Inc. Balance Sheet History
Metric Q2 FY2023 Q1 FY2023 Q4 FY2022 Q3 FY2022
Total Assets $67.78M$81.92M$94.05M$104.59M
Total Liabilities $35.76M$37.3M$39.87M$43.43M
Total Debt $26.58M$27.13M$27.5M$27.83M
Cash & Investments $26.18M$37.79M$48.67M$59.58M
Total Stockholders Equity $32.03M$44.63M$54.18M$61.17M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message